Abstract
A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.
Translated title of the contribution | The challenge to treat hypertensive patients with type 2 diabetes |
---|---|
Original language | French |
Pages (from-to) | S25-26 |
Journal | Presse médicale (Paris, France : 1983) |
Volume | 31 Spec No 2 |
State | Published - Oct 2002 |
ASJC Scopus subject areas
- Medicine(all)